Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

34.12
Delayed Data
As of Jul 31
 +0.485 / +1.44%
Today’s Change
31.34
Today|||52-Week Range
39.95
+0.18%
Year-to-Date

Stock Price Forecast

The 15 analysts offering 12-month price forecasts for Myriad Genetics Inc have a median target of 34.00, with a high estimate of 46.00 and a low estimate of 23.00. The median estimate represents a -0.35% decrease from the last price of 34.12.

Analyst Recommendations

The current consensus among 20 polled investment analysts is to Hold stock in Myriad Genetics Inc. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.41
Sales
$187.7M
Reporting Date
Aug 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 2.84%
 
 
 
 
 
 
Growthannually -40.03%
 
 
 
 
 
 

Sales

Growthquarterly 4.27%
 
 
 
 
 
 
Growthannually -7.41%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.